Press Release - Flash Therapeutics IRIS project

Flash Therapeutics announces that the IRIS project, for which it is the industrial partner, has been accepted for the 4th solicitation of bids for RHU projects of the « Programme d’Investissements d’Avenir »  

Flash Therapeutics, announces that the "IRIS" project has been accepted for the solicitation of bids by the « Recherche Hospitalo-Universitaire en santé » (RHU) for the Programme d'Investissement d'Avenir, supporting innovative and large-scale projects.

The IRIS project (InheRited Immune diSorders) is a gene therapy project for monogenic inherited diseases of the immune system.

To learn more, please, download the press release by  clicking here .

by Yohann Moal